+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiovascular Devices Market by Device Type, Operation Type, Access Type, Application, End User - Global Forecast to 2030- Product Image
Cardiovascular Devices Market by Device Type, Operation Type, Access Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Cardiovascular Devices Market by Device Type, Operation Type, Access Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336858
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiovascular Devices Market grew from USD 59.21 billion in 2024 to USD 63.77 billion in 2025. It is expected to continue growing at a CAGR of 7.82%, reaching USD 93.04 billion by 2030.

Understanding the Evolution of Cardiovascular Device Innovation

Cardiovascular diseases remain a leading cause of morbidity and mortality worldwide, exerting immense pressure on healthcare providers, payers, and patients. Driven by an aging population, shifting lifestyle factors, and the growing burden of chronic conditions, the demand for advanced cardiovascular devices has never been greater. From early detection through monitoring to life-saving therapeutic interventions, the sector spans a broad spectrum of technologies that are critical to improving patient outcomes and reducing healthcare costs.

This executive summary provides a concise yet thorough exploration of the cardiovascular devices landscape. By examining the transformative forces at play - from technological breakthroughs to shifting regulatory frameworks and market dynamics - decision-makers can better navigate emerging opportunities and challenges. The analysis that follows is designed to equip industry leaders, investors, and healthcare stakeholders with the insights necessary to align strategies, manage risks, and capitalize on key growth areas within this dynamic sector.

Key Drivers Reshaping the Cardiovascular Devices Industry Landscape

Over the past decade, the cardiovascular devices industry has undergone seismic shifts driven by digital transformation, novel materials, and patient-centric care models. Artificial intelligence and advanced data analytics are now integral to device development, enabling predictive diagnostics and personalized therapy optimization. At the same time, minimally invasive approaches have gained prominence, reducing procedural risk and accelerating patient recovery times.

Concurrently, regulatory agencies have adopted more agile frameworks to accelerate the approval of breakthrough therapies without compromising safety. Reimbursement models are also evolving toward value-based care, prioritizing long-term outcomes over procedural volumes. This confluence of factors has reshaped collaboration between device makers, healthcare providers, and technology partners, fostering ecosystems that emphasize interoperability, real-world evidence, and integrated care pathways.

Assessing the Ripple Effects of US Tariffs on Cardiac Device Supply Chains

In 2025, the introduction of renewed tariffs on imported goods in the United States has had far-reaching implications for the cardiovascular devices supply chain. Manufacturers reliant on overseas component sourcing have faced increased input costs, exerting upward pressure on final device pricing. Simultaneously, extended customs clearance times and complex compliance requirements have led to inventory bottlenecks, forcing some stakeholders to build buffer stocks and reconfigure logistics networks.

Hospitals and clinics have begun scrutinizing their procurement strategies, seeking alternative suppliers and exploring local manufacturing partnerships to mitigate disruption. In parallel, device makers are reassessing global production footprints to balance cost-efficiency with regulatory exposure. Despite near-term challenges, these adjustments may foster greater supply chain resilience and encourage strategic localization of critical manufacturing capabilities.

Illuminating Critical Market Segments for Targeted Growth

The cardiovascular devices market is defined by diverse segments, each with distinct growth drivers and investment requirements. Within the domain of diagnostic and monitoring solutions, systems such as electrocardiographs and implantable loop recorders are experiencing heightened demand as clinicians pursue earlier, more accurate detection of arrhythmias. In the surgical arena, cardiac stents and heart valves continue to evolve with novel materials and designs, while vascular graft innovations address complex anatomies. Therapeutic devices, encompassing blood pressure monitors through to pacemakers and implantable defibrillators, integrate telemetry capabilities and algorithmic management to support chronic disease management.

Operationally, the divide between invasive and non-invasive technologies underscores the industry’s balance between procedural efficacy and patient convenience. Non-invasive imaging and monitoring tools attract outpatient and at-home care models, whereas catheter-based interventions and surgical implants maintain a central role in acute and complex cases. Similarly, the choice between transcutaneous access and transvenous delivery systems influences device form factors, procedural protocols, and training pathways. Among clinical applications, cardiac rhythm management remains a core focus, complemented by solutions targeting coronary artery disease, peripheral vascular disease, and stroke prevention.

End users span ambulatory surgical centers that favor rapid-turnaround procedures, home care environments that prioritize patient self-management, and hospitals and clinics equipped for high-acuity interventions. This segmentation matrix offers a roadmap for resource allocation, strategic partnerships, and targeted innovation initiatives that align with the nuanced needs of each stakeholder group.

Regional Dynamics Shaping Cardiovascular Device Adoption Globally

Across the Americas, well-established reimbursement frameworks and advanced clinical infrastructures drive rapid uptake of next-generation devices, especially in regions with high procedural volumes. Market participants emphasize partnerships with leading hospital systems and invest in robust service networks to support device installation and maintenance. In contrast, Europe, the Middle East, and Africa present a heterogeneous landscape where diverse regulatory regimes and variable payer systems necessitate tailored market entry strategies. Key priorities include navigating stringent certification processes, leveraging regional health initiatives, and addressing affordability through tiered product offerings.

Asia-Pacific is distinguished by emerging economies that combine large patient populations with expanding healthcare expenditure. Stakeholders are tapping into local manufacturing hubs to control costs and benefit from favorable trade agreements. Rapid urbanization and government-driven healthcare reforms are accelerating demand for both diagnostic and therapeutic solutions, while digital health platforms gain traction as a bridge to remote and rural communities. Collectively, these regional dynamics underscore the importance of adaptive commercialization models and cross-border collaborations that respect local nuances.

Profiles of Leading Innovators Driving Market Advancement

Industry leaders are intensifying efforts across multiple fronts to secure sustainable competitive positions. Major enterprises have accelerated investments in R&D, focusing on miniaturization, material science advances, and closed-loop therapeutic systems. Collaborations between device developers and software innovators are producing integrated platforms that deliver realtime patient insights, while strategic acquisitions bolster pipelines and expand geographic reach.

Some companies are pioneering novel financing arrangements and value-based contracting to align incentives across the care continuum. Others are forging alliances with academic institutions and clinical networks to generate robust clinical data and accelerate regulatory submissions. Meanwhile, smaller specialized manufacturers are capturing niche opportunities through agile operations and targeted product portfolios, often leveraging digital marketing channels to engage physicians and payers directly.

Strategic Imperatives for Industry Leaders to Seal Competitive Advantage

To thrive amid intensifying competition and evolving payer landscapes, industry players must pursue a multifaceted approach. First, diversifying supply chains by establishing regional manufacturing footprints and alternative sourcing partnerships will mitigate the impact of trade disruptions. Second, embedding software and connectivity capabilities into devices will support remote monitoring, patient engagement, and data-driven service offerings. Third, aligning with value-based care initiatives through outcome-based pricing and postmarket evidence collection can unlock new reimbursement pathways.

Additionally, proactive engagement with regulatory agencies and participation in standard-setting consortia will expedite product approvals and enhance interoperability. Investing in talent across clinical, regulatory, and digital domains will be critical for driving sustained innovation. Finally, forging cross-sector partnerships-spanning payers, providers, and technology companies-will enable the creation of holistic care ecosystems that deliver superior outcomes and foster long-term market leadership.

Rigorous Research Framework Underpinning Market Insights

This report is grounded in a structured, dual-phase research methodology combining rigorous primary and secondary analysis. Primary research involved in-depth interviews with key opinion leaders, senior executives at device manufacturers, clinical authorities, and reimbursement specialists, yielding firsthand perspectives on market drivers, barriers, and unmet needs. Secondary research encompassed a comprehensive review of peer-reviewed journals, regulatory filings, patent databases, company annual reports, and proprietary industry databases to triangulate findings and validate market trends.

Quantitative data on product approvals, procedure volumes, and import-export flows were integrated with qualitative insights to produce a nuanced assessment of emerging opportunities. Each data set underwent stringent quality checks and cross-comparison to ensure consistency and reliability. The research framework emphasizes transparency, repeatability, and methodological rigor, providing stakeholders with a solid foundation for strategic decision-making in the cardiovascular devices sector.

Concluding Perspectives on the Future of Cardiovascular Devices

As the cardiovascular devices market continues to navigate dynamic technological, regulatory, and economic currents, stakeholders who remain agile and informed will secure the greatest reward. This analysis has distilled the pivotal shifts, structural trends, and tactical imperatives that define the current landscape. By harnessing the actionable insights presented here, decision-makers can anticipate challenges, allocate resources effectively, and foster innovation that aligns with evolving clinical needs.

Looking ahead, the convergence of digital health, precision medicine, and value-based care will shape the next frontier of cardiovascular interventions. Organizations that integrate these dimensions into coherent strategies will be best positioned to deliver patient-centric solutions, achieve operational efficiencies, and drive sustainable growth across global markets.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Device Type
    • Diagnostic & Monitoring Devices
      • ECG Systems
      • Electrode Leads & Accessories
      • Event Monitors
      • Holter Monitors
      • Implantable Loop Recorders
    • Surgical Devices
      • Cardiac Stents
      • Catheters
      • Heart Valves
      • Vascular Grafts
    • Therapeutic Devices
      • Blood Pressure Monitors
      • Defibrillators
      • Pacemakers
  • Operation Type
    • Invasive Devices
    • Non-Invasive Devices
  • Access Type
    • Transcutaneous
    • Transvenous
  • Application
    • Cardiac Rhythm Management
    • Coronary Artery Disease
    • Peripheral Vascular Disease
    • Stroke Management
  • End User
    • Ambulatory Surgical Centers
    • Home Care
    • Hospitals & Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • ACS Diagnostics
  • Alivecor, Inc.
  • Asahi Kasei Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Bexen Medical
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • BPL Medical Technologies Private Limited
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • HeartFlow Holding, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.,
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Microport Scientific Corporation
  • Nihon Kohden Corporation
  • Schiller AG
  • Siemens Healthineers
  • Terumo Cardiovascular Systems Corporation
  • Tricog Health
  • Vesalius Cardiovascular Inc.
  • Zoll Medical Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. An In-Depth Overview of the Cardiovascular Devices Market's Current Position and Influencing Factors Shaping Its Expansion and Challenges
3.2. Detailed Analysis of Consumer Preferences Trends Competitive Dynamics and Regulatory Variations Across Regions in Cardiovascular Devices Market
3.3. Comprehensive Evaluation of Intellectual Property Landscape and Formulation of a Robust Commercialization Strategy for Sustained Market Growth
3.4. Future Market Outlook Across Development Stages Emerging Technologies and Growth Opportunities in Cardiovascular Devices
4. Market Overview
4.1. Introduction
4.1.1. Comprehensive Scope and Definition of the Cardiovascular Devices Market Highlighting Growth Opportunities and Challenges
4.1.2. In-Depth Geographic Overview of Global Cardiovascular Devices Market Dynamics and Regional Influences
4.1.3. Recent Market Developments and Regulatory Analysis Featuring Breakthroughs Investments and Industry Collaborations in Cardiovascular Devices
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in minimally invasive cardiovascular devices improving patient outcomes
5.1.1. Trend Definition and Context of Advancements in Minimally Invasive Cardiovascular Devices Improving Patient Outcomes
5.1.2. Impact of Minimally Invasive Cardiovascular Devices Advancements on Market Dynamics and Opportunities
5.1.3. Future Outlook and Strategic Implications of Minimally Invasive Cardiovascular Devices Advancements on Market and Stakeholders
5.2. Rising adoption of wearable cardiovascular monitors for real-time health tracking
5.2.1. Trend Definition and Context of Wearable Cardiovascular Monitors in Real-Time Health Tracking
5.2.2. Market Impact of Rising Adoption of Wearable Cardiovascular Monitors on Healthcare Innovation and Demand
5.2.3. Future Outlook and Strategic Implications for Stakeholders Adopting Wearable Cardiovascular Monitors
5.3. Integration of AI and machine learning in cardiovascular device diagnostics and treatments
5.3.1. Trend Definition and Context of AI and Machine Learning Integration in Cardiovascular Devices Diagnostics and Treatments
5.3.2. Market Impact of AI and Machine Learning in Transforming Cardiovascular Device Diagnostics and Treatments
5.3.3. Future Outlook and Strategic Implications of AI and Machine Learning in Cardiovascular Device Diagnostics and Treatments
5.4. Growth of biodegradable stents enhancing safety and reducing complications
5.4.1. Understanding the Growth of Biodegradable Stents Enhancing Safety and Reducing Complications in Cardiovascular Devices
5.4.2. Analyzing How Biodegradable Stents Are Transforming Market Dynamics and Unlocking Innovation Opportunities
5.4.3. Evaluating the Future Trajectory and Strategic Implications of the Biodegradable Stent Trend in Cardiovascular Care
5.5. Innovations in drug-eluting stents driving better recovery rates in patients
5.5.1. Comprehensive definition and contextual background highlighting innovations in drug-eluting stents enhancing patient recovery rates
5.5.2. In-depth analysis of market transformation and emerging opportunities driven by advanced drug-eluting stents
5.5.3. Future trajectory and strategic implications of evolving drug-eluting stent technologies within cardiovascular care
5.6. Expansion of remote monitoring systems for cardiovascular disease management
5.6.1. Comprehensive definition and contextual background of remote cardiovascular monitoring systems highlighting driving factors
5.6.2. In-depth analysis of how remote monitoring transforms cardiovascular device market dynamics and unlocks business opportunities
5.6.3. Future perspective on remote cardiovascular monitoring including implications, risks, and strategic recommendations
5.7. Emergence of 3D printing technology in custom cardiovascular implant fabrication
5.7.1. Trend Definition and Context: Understanding the Rise of 3D Printing in Custom Cardiovascular Implant Fabrication
5.7.2. Market Impact Analysis: How 3D Printing is Shaping the Cardiovascular Device Industry Landscape
5.7.3. Future Outlook and Strategic Implications for Stakeholders in 3D Printed Cardiovascular Implants
5.8. Increasing demand for robotic-assisted cardiovascular surgeries boosting precision
5.8.1. Robotic-assisted Cardiovascular Surgeries Defined with Key Characteristics and Driving Factors in the Market Context
5.8.2. Transformation of the Cardiovascular Devices Market through Robotic Surgery and Emerging Business Opportunities
5.8.3. Future Trajectory and Strategic Considerations for Robotic-Assisted Cardiovascular Surgery in Market Evolution
5.9. Development of next-generation implantable cardioverter-defibrillators with enhanced features
5.9.1. Clear definition and contextual background of next-generation implantable cardioverter-defibrillators and their enhanced features
5.9.2. Market transformation and opportunity creation driven by advanced implantable cardioverter-defibrillator features
5.9.3. Future trajectory and strategic implications of developing advanced implantable cardioverter-defibrillators
5.10. Focus on personalized cardiovascular therapies through genetic and biomarker analysis
5.10.1. Comprehensive definition and context of personalized cardiovascular therapies through genetic and biomarker analysis
5.10.2. In-depth analysis of market impact driven by personalized cardiovascular therapies through genetic and biomarker analysis
5.10.3. Future outlook and strategic implications of personalized cardiovascular therapies driven by genetic and biomarker analysis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.1.1. Threat of New Entrants in the Cardiovascular Devices Market Considering Entry Barriers and Regulatory Challenges
6.1.2. Threat of Substitute Products in Cardiovascular Devices Driven by Technology and Consumer Preferences
6.1.3. Bargaining Power of Suppliers in Cardiovascular Devices Regarding Supplier Concentration and Input Uniqueness
6.1.4. Bargaining Power of Buyers in Cardiovascular Devices Considering Buyer Concentration and Price Sensitivity
6.1.5. Industry Rivalry in Cardiovascular Devices Highlighting Competition Based on Innovation and Pricing Strategies
6.2. PESTLE Analysis
6.2.1. Political factors shaping market dynamics through healthcare policy, regulation, and stability issues
6.2.2. Economic trends impacting market growth through healthcare spending, income levels, and macroeconomic stability
6.2.3. Social trends driving demand through demographic shifts, disease prevalence, and patient awareness
6.2.4. Technological innovations shaping the market through AI, minimally invasive devices, and digital integration
6.2.5. Legal frameworks influencing market entry, compliance costs, and intellectual property protection
6.2.6. Environmental factors affecting the market through sustainability initiatives, regulatory pressures, and supply chain risks
7. Cumulative Impact of United States Tariffs 2025
7.1. An overview of notable tariffs implemented by the United States on the market from 2023 to 2025 including major tariffs affecting the market with their rates and timelines
7.2. The historical background of United States tariff policies and their intended economic rationale from 2018 to 2025 on developed and developing countries
7.3. An analysis of how recent tariff implementations have directly contributed to inflation in the Global economy with supporting data or statistics
7.4. An examination of the implications of reciprocal tariffs between the United States and its trading partners highlighting significant trade wars and broader geopolitical context
7.5. An evaluation of the economic and political consequences of United States tariffs on major trading partners including immediate and long-term economic effects
7.6. Identification of long-term structural changes in the United States economy due to tariff policies including shifts in supply chains industry relocations and impacts on consumer choices and purchasing power
7.7. Suggested policy responses and strategies to mitigate negative impacts of tariffs on the United States economy and its trading partners
8. Cardiovascular Devices Market, by Device Type
8.1. Introduction
8.2. Diagnostic & Monitoring Devices
8.2.1. ECG Systems
8.2.2. Electrode Leads & Accessories
8.2.3. Event Monitors
8.2.4. Holter Monitors
8.2.5. Implantable Loop Recorders
8.3. Surgical Devices
8.3.1. Cardiac Stents
8.3.2. Catheters
8.3.3. Heart Valves
8.3.4. Vascular Grafts
8.4. Therapeutic Devices
8.4.1. Blood Pressure Monitors
8.4.2. Defibrillators
8.4.3. Pacemakers
9. Cardiovascular Devices Market, by Operation Type
9.1. Introduction
9.2. Invasive Devices
9.3. Non-Invasive Devices
10. Cardiovascular Devices Market, by Access Type
10.1. Introduction
10.2. Transcutaneous
10.3. Transvenous
11. Cardiovascular Devices Market, by Application
11.1. Introduction
11.2. Cardiac Rhythm Management
11.3. Coronary Artery Disease
11.4. Peripheral Vascular Disease
11.5. Stroke Management
12. Cardiovascular Devices Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Home Care
12.4. Hospitals & Clinics
13. Americas Cardiovascular Devices Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cardiovascular Devices Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cardiovascular Devices Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.1.1. In-depth analysis of Abbott Laboratories flagship cardiovascular products and their market differentiation
16.3.1.2. Comprehensive risk and vulnerability assessment with strategic recommendations for Abbott Laboratories in cardiovascular market
16.3.2. ACS Diagnostics
16.3.2.1. In-depth analysis of ACS Diagnostics flagship cardiovascular devices and market alignment
16.3.2.2. Comprehensive risk analysis and strategic pathways for ACS Diagnostics to strengthen future growth
16.3.3. Alivecor, Inc.
16.3.3.1. In-depth Analysis of Alivecor's Flagship Cardiovascular Monitoring Devices and Their Market Positioning
16.3.3.2. Comprehensive Risk Assessment and Strategic Recommendations for Enhancing Alivecor’s Market Growth and Innovation
16.3.4. Asahi Kasei Corporation
16.3.4.1. In-depth Analysis of Asahi Kasei’s Leading Cardiovascular Products and Their Market Alignment
16.3.4.2. Comprehensive Risk Assessment and Strategic Recommendations to Strengthen Asahi Kasei’s Cardiovascular Market Position
16.3.5. B. Braun SE
16.3.5.1. In-depth analysis of flagship cardiovascular products and services that meet evolving patient and clinician needs
16.3.5.2. Comprehensive evaluation of risks and actionable strategies to strengthen market presence and future growth
16.3.6. Baxter International Inc.
16.3.6.1. Comprehensive overview of Baxter International's core products and competitive advantages in cardiovascular care
16.3.6.2. In-depth risk assessment and strategic growth recommendations to bolster Baxter International's market resilience and innovation pipeline
16.3.7. Bexen Medical
16.3.7.1. Comprehensive Identification and Detailed Analysis of Bexen Medical's Flagship Cardiovascular Products and Services Catering Directly to Target Markets
16.3.7.2. Thorough Risk and Vulnerability Assessment with Actionable Strategies to Strengthen Bexen Medical's Market Position and Product Portfolio Overcoming Industry Challenges
16.3.8. Biotronik SE & Co KG
16.3.8.1. In-depth analysis of Biotronik’s flagship cardiovascular devices highlighting key features and market alignment
16.3.8.2. Comprehensive risk analysis and strategic recommendations to enhance Biotronik’s growth and product portfolio
16.3.9. Boston Scientific Corporation
16.3.9.1. Detailed analysis of flagship cardiovascular devices and their alignment with healthcare provider needs
16.3.9.2. Comprehensive identification of risks along with strategic approaches to mitigate vulnerabilities and capitalize on emerging market trends
16.3.10. BPL Medical Technologies Private Limited
16.3.10.1. Detailed Examination of BPL Medical Technologies’ Flagship Cardiovascular Devices and Their Market Differentiators
16.3.10.2. Comprehensive Risk Analysis and Strategic Recommendations for Enhancing BPL Medical Technologies’ Market Position and Product Portfolio
16.3.11. Edwards Lifesciences Corporation
16.3.11.1. A detailed overview of Edwards Lifesciences' strategic positioning and market presence highlighting its core strengths and geographic influence
16.3.11.2. An in-depth exploration of Edwards Lifesciences’ flagship cardiovascular devices emphasizing product features and market alignment
16.3.11.3. A comprehensive risk and vulnerability assessment focusing on Edwards Lifesciences’ strategic opportunities to counter threats and enhance growth
16.3.12. GE Healthcare
16.3.12.1. In-depth analysis of GE Healthcare's flagship cardiovascular products and services aligning with market needs
16.3.12.2. Comprehensive risk identification and strategic mitigation plans for GE Healthcare’s cardiovascular market challenges
16.3.13. HeartFlow Holding, Inc.
16.3.13.1. Comprehensive Analysis of HeartFlow Holding, Inc.'s Flagship Products and Their Market Differentiation
16.3.13.2. In-Depth Risk Assessment and Forward-Looking Strategies for Sustained Market Leadership by HeartFlow Holding, Inc.
16.3.14. Johnson & Johnson Services, Inc.
16.3.14.1. In-depth exploration of Johnson & Johnson’s flagship cardiovascular devices and aligned services that cater directly to the market's evolving needs
16.3.14.2. Comprehensive risk and vulnerability assessment with actionable strategic recommendations for Johnson & Johnson Services, focusing on sustaining growth and addressing emerging market trends
16.3.15. Koninklijke Philips N.V.,
16.3.15.1. Focused overview of Koninklijke Philips N.V.’s role and strategic positioning in the cardiovascular market including milestones and geographic presence
16.3.15.2. Comprehensive analysis of flagship cardiovascular products and services demonstrating innovation and competitive advantage
16.3.15.3. In-depth risk assessment highlighting vulnerabilities and strategic recommendations for growth in cardiovascular devices market
16.3.16. Lepu Medical Technology(Beijing)Co.,Ltd.
16.3.16.1. An in-depth exploration of Lepu Medical Technology's flagship cardiovascular products and their market relevance
16.3.16.2. Comprehensive assessment of risks and vulnerabilities facing Lepu Medical Technology with strategic recommendations for future growth
16.3.17. LivaNova PLC
16.3.17.1. In-depth examination of LivaNova PLC's flagship cardiovascular and neuromodulation products with emphasis on innovation and user benefits
16.3.17.2. Comprehensive risk and vulnerability assessment for LivaNova PLC with strategic recommendations to bolster innovation and market presence
16.3.18. Medtronic PLC
16.3.18.1. In-depth analysis of Medtronic's flagship cardiovascular products and services highlighting innovation and market alignment
16.3.18.2. Comprehensive assessment of risks and vulnerabilities with strategic recommendations to enhance Medtronic's product portfolio and market position over the next years
16.3.19. Microport Scientific Corporation
16.3.19.1. In-Depth Review of MicroPort Scientific Corporation's Leading Product Lines That Meet Cardiac Care Demands
16.3.19.2. Strategic Risk Analysis and Opportunities for Portfolio Diversification to Strengthen Market Position
16.3.20. Nihon Kohden Corporation
16.3.20.1. In-depth Analysis of Nihon Kohden's Flagship Cardiovascular Products and their Market Impact
16.3.20.2. Comprehensive Risk and Vulnerability Assessment Highlighting Strategic Growth Opportunities for Nihon Kohden
16.3.21. Schiller AG
16.3.21.1. An in-depth overview of Schiller AG’s flagship products and services targeting cardiovascular healthcare providers
16.3.21.2. A comprehensive risk and vulnerability assessment with actionable strategies for Schiller AG to sustain growth and innovation in cardiovascular technology
16.3.22. Siemens Healthineers
16.3.22.1. In-depth evaluation of Siemens Healthineers flagship cardiovascular products showing their strategic alignment with market needs
16.3.22.2. Comprehensive risk and vulnerability assessment including actionable strategies for Siemens Healthineers to future-proof its cardiovascular device business
16.3.23. Terumo Cardiovascular Systems Corporation
16.3.23.1. Detailed analysis of Terumo Cardiovascular’s flagship products addressing surgical needs and market demands with unique competitive advantages
16.3.23.2. Comprehensive risk and vulnerability assessment coupled with strategic initiatives to boost Terumo Cardiovascular’s market resilience and innovation capacity
16.3.24. Tricog Health
16.3.24.1. In-depth analysis of Tricog Health’s flagship cardiovascular diagnostic products and service offerings enhancing market reach and patient outcomes
16.3.24.2. Comprehensive assessment of risks and vulnerabilities facing Tricog Health with strategic recommendations for future growth and product diversification
16.3.25. Vesalius Cardiovascular Inc.
16.3.25.1. Flagship Products and Services that Drive Innovation and Market Leadership in Cardiovascular Devices
16.3.25.2. Detailed Risk and Vulnerability Assessment with Strategic Growth Opportunities for Vesalius Cardiovascular
16.3.26. Zoll Medical Corporation
16.3.26.1. In-depth analysis of Zoll Medical Corporation’s flagship cardiovascular devices and their market alignment
16.3.26.2. Comprehensive risk evaluation and strategic recommendations for Zoll Medical Corporation’s sustained market growth
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CARDIOVASCULAR DEVICES MARKET MULTI-CURRENCY
FIGURE 2. CARDIOVASCULAR DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. CARDIOVASCULAR DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CARDIOVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ECG SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTRODE LEADS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY EVENT MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE LOOP RECORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INVASIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY NON-INVASIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY TRANSCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY TRANSVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STROKE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 59. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 60. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 61. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 62. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 108. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 109. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 110. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 111. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 112. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 113. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 117. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 133. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 134. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 135. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 137. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 140. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 141. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 142. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 143. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 144. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 145. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 172. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 173. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 174. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 175. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 176. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 177. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 189. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 190. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 191. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 192. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 193. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 198. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 199. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 200. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 201. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 220. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 221. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 222. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 223. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 224. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 225. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 229. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 230. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 231. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 232. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 233. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 246. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 247. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 248. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 249. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 253. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 254. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 255. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 256. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 257. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 276. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 277. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 278. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 279. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 280. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 281. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 282. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 285. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 286. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 287. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 288. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 289. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 290. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 293. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 294. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 295. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 296. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 297. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 298. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 325. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-

Companies Mentioned

The companies profiled in this Cardiovascular Devices market report include:
  • Abbott Laboratories
  • ACS Diagnostics
  • Alivecor, Inc.
  • Asahi Kasei Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Bexen Medical
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • BPL Medical Technologies Private Limited
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • HeartFlow Holding, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.,
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Microport Scientific Corporation
  • Nihon Kohden Corporation
  • Schiller AG
  • Siemens Healthineers
  • Terumo Cardiovascular Systems Corporation
  • Tricog Health
  • Vesalius Cardiovascular Inc.
  • Zoll Medical Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 63.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 93.04 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

United States Cardiovascular Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

United States Cardiovascular Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 125 Pages
  • United States
From
Cardiovascular Devices Market Report 2025 - Product Image

Cardiovascular Devices Market Report 2025

  • Report
  • 400 Pages
  • Global
From
Cardiovascular Surgery Devices Market by Product, End User, Technology, Procedure, Application - Global Forecast to 2030 - Product Image

Cardiovascular Surgery Devices Market by Product, End User, Technology, Procedure, Application - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Cardiovascular Anastomosis Devices Market by Product Type, Mechanism, Procedure Type, End User - Global Forecast to 2030 - Product Image

Cardiovascular Anastomosis Devices Market by Product Type, Mechanism, Procedure Type, End User - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring (ECG, Holter), Surgical Devices (Pacemakers, Stents)), By Region (Europe. APAC, MEA), And Segment Forecasts, 2025 - 2030 - Product Image

Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring (ECG, Holter), Surgical Devices (Pacemakers, Stents)), By Region (Europe. APAC, MEA), And Segment Forecasts, 2025 - 2030

  • Report
  • 240 Pages
  • Global
From

About the Cardiovascular Devices Market

The Cardiovascular Devices market is a segment of the medical device industry that focuses on the diagnosis, treatment, and prevention of cardiovascular diseases. It includes a range of products such as pacemakers, stents, catheters, and other implantable devices. These devices are used to diagnose and treat conditions such as arrhythmia, heart failure, and coronary artery disease. The market is driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. Additionally, the rising geriatric population and the increasing awareness of cardiovascular diseases are expected to drive the market growth. Some of the major companies in the Cardiovascular Devices market include Medtronic, Abbott Laboratories, Boston Scientific Corporation, St. Jude Medical, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.